Literature DB >> 26067258

The Roles of Mitochondrial Damage-Associated Molecular Patterns in Diseases.

Kiichi Nakahira1,2, Shu Hisata1,2, Augustine M K Choi1,2.   

Abstract

SIGNIFICANCE: Mitochondria, vital cellular power plants to generate energy, are involved in immune responses. Mitochondrial damage-associated molecular patterns (DAMPs) are molecules that are released from mitochondria to extracellular space during cell death and include not only proteins but also DNA or lipids. Mitochondrial DAMPs induce inflammatory responses and are critically involved in the pathogenesis of various diseases. RECENT ADVANCES: Recent studies elucidate the molecular mechanisms by which mitochondrial DAMPs are released and initiate immune responses by use of genetically modulated cells or animals. Importantly, the levels of mitochondrial DAMPs in patients are often associated with severity and prognosis of human diseases, such as infection, asthma, ischemic heart disease, and cancer. CRITICAL ISSUES: Although mitochondrial DAMPs can represent proinflammatory molecules in various experimental models, their roles in human diseases may be multifunctional and complex. It remains unclear where and how mitochondrial DAMPs are liberated into extracellular spaces and exert their biological functions particularly in vivo. In addition, while mitochondria can secrete several types of DAMPs during cell death, the interaction of each mitochondrial DAMP (e.g., synergistic effects) remains unclear. FUTURE DIRECTIONS: Regulation of mitochondrial DAMP-mediated immune responses may be important to alter the progression of human diseases. In addition, measuring mitochondrial DAMPs in patients may be clinically useful as biomarkers to predict prognosis or response to therapies. Further studies of the mechanisms by which mitochondrial DAMPs impact the initiation and progression of diseases may lead to the development of therapeutics specifically targeting this pathway. Antioxid.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26067258      PMCID: PMC4685486          DOI: 10.1089/ars.2015.6407

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  182 in total

1.  Metabolic signatures of exercise in human plasma.

Authors:  Gregory D Lewis; Laurie Farrell; Malissa J Wood; Maryann Martinovic; Zoltan Arany; Glenn C Rowe; Amanda Souza; Susan Cheng; Elizabeth L McCabe; Elaine Yang; Xu Shi; Rahul Deo; Frederick P Roth; Aarti Asnani; Eugene P Rhee; David M Systrom; Marc J Semigran; Ramachandran S Vasan; Steven A Carr; Thomas J Wang; Marc S Sabatine; Clary B Clish; Robert E Gerszten
Journal:  Sci Transl Med       Date:  2010-05-26       Impact factor: 17.956

2.  Mitochondrial permeability transition triggers the release of mtDNA fragments.

Authors:  M Patrushev; V Kasymov; V Patrusheva; T Ushakova; V Gogvadze; A Gaziev
Journal:  Cell Mol Life Sci       Date:  2004-12       Impact factor: 9.261

Review 3.  Pathophysiology and therapeutic potential of purinergic signaling.

Authors:  Geoffrey Burnstock
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

Review 4.  Intracellular DNA recognition.

Authors:  Veit Hornung; Eicke Latz
Journal:  Nat Rev Immunol       Date:  2010-02       Impact factor: 53.106

Review 5.  Mitochondria in innate immunity.

Authors:  Damien Arnoult; Fraser Soares; Ivan Tattoli; Stephen E Girardin
Journal:  EMBO Rep       Date:  2011-09-01       Impact factor: 8.807

6.  Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages.

Authors:  Kohki Kawane; Mayumi Ohtani; Keiko Miwa; Takuji Kizawa; Yoshiyuki Kanbara; Yoshichika Yoshioka; Hideki Yoshikawa; Shigekazu Nagata
Journal:  Nature       Date:  2006-10-26       Impact factor: 49.962

7.  Frequent truncating mutation of TFAM induces mitochondrial DNA depletion and apoptotic resistance in microsatellite-unstable colorectal cancer.

Authors:  Jianhui Guo; Li Zheng; Wenyong Liu; Xianshu Wang; Zemin Wang; Zehua Wang; Amy J French; Dongchon Kang; Lin Chen; Stephen N Thibodeau; Wanguo Liu
Journal:  Cancer Res       Date:  2011-04-05       Impact factor: 12.701

8.  Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.

Authors:  Corina Kohler; Ramin Radpour; Zeinab Barekati; Reza Asadollahi; Johannes Bitzer; Edward Wight; Nicole Bürki; Claude Diesch; Wolfgang Holzgreve; Xiao Yan Zhong
Journal:  Mol Cancer       Date:  2009-11-17       Impact factor: 27.401

9.  Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis.

Authors:  Zufeng Ding; Shijie Liu; Xianwei Wang; Magomed Khaidakov; Yao Dai; Jawahar L Mehta
Journal:  Sci Rep       Date:  2013-01-16       Impact factor: 4.379

10.  Plasma levels of mitochondrial and nuclear DNA in patients with massive pulmonary embolism in the emergency department: a prospective cohort study.

Authors:  Francisco Arnalich; Maria Constanza Maldifassi; Enrique Ciria; Rosa Codoceo; Jaime Renart; Carmen Fernández-Capitán; Rafael Herruzo; Francisco Garcia-Rio; Eduardo López-Collazo; Carmen Montiel
Journal:  Crit Care       Date:  2013-05-24       Impact factor: 9.097

View more
  87 in total

1.  A phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDS.

Authors:  Laura E Fredenburgh; Mark A Perrella; Diana Barragan-Bradford; Dean R Hess; Elizabeth Peters; Karen E Welty-Wolf; Bryan D Kraft; R Scott Harris; Rie Maurer; Kiichi Nakahira; Clara Oromendia; John D Davies; Angelica Higuera; Kristen T Schiffer; Joshua A Englert; Paul B Dieffenbach; David A Berlin; Susan Lagambina; Mark Bouthot; Andrew I Sullivan; Paul F Nuccio; Mamary T Kone; Mona J Malik; Maria Angelica Pabon Porras; Eli Finkelsztein; Tilo Winkler; Shelley Hurwitz; Charles N Serhan; Claude A Piantadosi; Rebecca M Baron; B Taylor Thompson; Augustine Mk Choi
Journal:  JCI Insight       Date:  2018-12-06

2.  Bacterial Type I CRISPR-Cas systems influence inflammasome activation in mammalian host by promoting autophagy.

Authors:  Qun Wu; Biao Wang; Chuanmin Zhou; Ping Lin; Shugang Qin; Pan Gao; Zhihan Wang; Zhenwei Xia; Min Wu
Journal:  Immunology       Date:  2019-09-17       Impact factor: 7.397

Review 3.  Mitochondrial Dysfunction in Airway Disease.

Authors:  Y S Prakash; Christina M Pabelick; Gary C Sieck
Journal:  Chest       Date:  2017-03-21       Impact factor: 9.410

4.  Mitochondrial Dysfunction: Metabolic Drivers of Pulmonary Hypertension.

Authors:  Hagir B Suliman; Eva Nozik-Grayck
Journal:  Antioxid Redox Signal       Date:  2019-02-25       Impact factor: 8.401

Review 5.  A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease.

Authors:  Zhi Zhong; John J Lemasters
Journal:  Alcohol Clin Exp Res       Date:  2018-09-17       Impact factor: 3.455

6.  Role of mitochondrial depolarization and disrupted mitochondrial homeostasis in non-alcoholic steatohepatitis and fibrosis in mice.

Authors:  Yasodha Krishnasamy; Monika Gooz; Li Li; John J Lemasters; Zhi Zhong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2019-10-15

Review 7.  Mitochondrial DNA in Sepsis.

Authors:  John S Harrington; Augustine M K Choi; Kiichi Nakahira
Journal:  Curr Opin Crit Care       Date:  2017-08       Impact factor: 3.687

8.  Cell free mitochondrial DNA in serum and milk associated with bovine mastitis: a pilot study.

Authors:  Geeta Devi Leishangthem; Niraj Kumar Singh; Nittin Dev Singh; Gursimran Filia; Amarjit Singh
Journal:  Vet Res Commun       Date:  2018-08-25       Impact factor: 2.459

9.  Extracellular Mitochondria and Mitochondrial Components Act as Damage-Associated Molecular Pattern Molecules in the Mouse Brain.

Authors:  Heather M Wilkins; Scott J Koppel; Ian W Weidling; Nairita Roy; Lauren N Ryan; John A Stanford; Russell H Swerdlow
Journal:  J Neuroimmune Pharmacol       Date:  2016-08-25       Impact factor: 4.147

Review 10.  Carbon monoxide in the treatment of sepsis.

Authors:  Kiichi Nakahira; Augustine M K Choi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-23       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.